Back
Cogent Biosciences Vs. Apellis Pharmaceuticals Industry Stock Comparison
Sell
42
COGT
Cogent Biosciences
Last Price:
$4.93
Seasonality Move:
104.35%
Sell
31
APLS
Apellis Pharmaceuticals
Last Price:
$16.86
Seasonality Move:
2.29%
Sell
42
Cogent Biosciences (COGT)
is a Sell
Is Cogent Biosciences a Buy, Sell or Hold?
-
The current Cogent Biosciences [COGT] share price is $4.88. The Score for COGT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
COGT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $16.89. The Score for APLS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
COGT Stock Price Chart
What is Cogent Biosciences's stock price today?
-
The Cogent Biosciences share price today is $4.88The current trend is moderately bearish and COGT is experiencing slight selling pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $16.89Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
COGT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 46.72 | Sell |
Chaikin Money Flow: | -214060 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.61 - 5.31) | Sell |
Bollinger Bands (100): | (5.07 - 8.31) | Sell |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.69 | Sell |
Relative Strength Index (14 RSI): | 39.8 | Sell |
Chaikin Money Flow: | -1646043 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.94 - 18.98) | Sell |
Bollinger Bands (100): | (19.09 - 29.47) | Sell |
COGT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.95 | Sell |
20-day SMA: | 5.05 | Sell |
50-day SMA: | 5.31 | Sell |
200-day SMA: | 8.39 | Sell |
8-day EMA: | 4.94 | Sell |
20-day EMA: | 4.91 | Sell |
50-day EMA: | 4.26 | Buy |
200-day EMA: | 1.92 | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.44 | Sell |
20-day SMA: | 18.05 | Sell |
50-day SMA: | 19.82 | Sell |
200-day SMA: | 28.44 | Sell |
8-day EMA: | 17.46 | Sell |
20-day EMA: | 17.93 | Sell |
50-day EMA: | 19.97 | Sell |
200-day EMA: | 28.55 | Sell |
Cogent Biosciences Earnings Growth & COGT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.21 per share, and an increase next year of $0.33 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.
Cogent Biosciences Technical Analysis
May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |